We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$396B
AUM Growth
-$4.47B
Cap. Flow
+$17.3B
Cap. Flow %
4.36%
Top 10 Hldgs %
17.57%
Holding
6,885
New
459
Increased
2,707
Reduced
2,368
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 15.47%
2 Healthcare 9.44%
3 Financials 9.02%
4 Consumer Discretionary 7.88%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENCPW
5776
DELISTED
Energem Corp Warrant
ENCPW
$23K ﹤0.01%
227,390
AMTI
5777
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$23K ﹤0.01%
23,192
-22,837
-50% -$40.3K
CBRGW
5778
DELISTED
Chain Bridge I Warrants
CBRGW
$23K ﹤0.01%
194,741
CLSD
5779
DELISTED
Clearside Biomedical
CLSD
$22K ﹤0.01%
1,287
-121
-9% -$2.65K
CRDF icon
5780
Cardiff Oncology
CRDF
$74.1M
$22K ﹤0.01%
14,349
-27,503
-66% -$66.2K
FBRX icon
5781
Forte Biosciences
FBRX
$1.57B
$22K ﹤0.01%
815
-497
-38% -$15.8K
VTGN icon
5782
VistaGen Therapeutics
VTGN
$12.5M
$22K ﹤0.01%
4,828
-17,825
-79% -$177K
CSLMR
5783
DELISTED
CSLM Acquisition Corp. Right
CSLMR
$22K ﹤0.01%
+245,000
New +$26.7K
CYT
5784
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$22K ﹤0.01%
11,670
-12,769
-52% -$33.3K
VAPO
5785
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$22K ﹤0.01%
1,783
-5,059
-74% -$79K
IGICW
5786
DELISTED
International General Insurance Holdings Ltd. Warrants expiring 03/17/2025
IGICW
$22K ﹤0.01%
38,943
MONDW
5787
DELISTED
Mondee Holdings, Inc. Warrant
MONDW
$22K ﹤0.01%
34,951
MSAIW icon
5788
MultiSensor AI Holdings Warrant
MSAIW
$784K
$21K ﹤0.01%
201,371
ZEOWW
5789
Zeo Energy Corp Warrants
ZEOWW
$103K
$21K ﹤0.01%
259,710
CITEW
5790
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$21K ﹤0.01%
210,478
-16,000
-7% -$2.63K
ALORW
5791
DELISTED
ALSP Orchid Acquisition Corp I Warrant
ALORW
$21K ﹤0.01%
232,653
-2,400
-1% -$275
LTRPA
5792
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$21K ﹤0.01%
19,234
-375,784
-95% -$396K
CCV.WS
5793
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$21K ﹤0.01%
245,777
-25,193
-9% -$5.05K
FATH
5794
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$21K ﹤0.01%
+524
New +$36K
ONCR
5795
DELISTED
Oncorus, Inc.
ONCR
$21K ﹤0.01%
24,411
-93,514
-79% -$120K
VLNS
5796
DELISTED
The Valens Company, Inc. Common Shares
VLNS
$21K ﹤0.01%
31,420
AENTW icon
5797
Alliance Entertainment Holding Corp Warrants
AENTW
$4.27M
$20K ﹤0.01%
104,273
AERTW
5798
Aeries Technology Warrant
AERTW
$891K
$20K ﹤0.01%
222,121
RDHL
5799
Redhill Biopharma
RDHL
$4.07M
$20K ﹤0.01%
39
+3
+8% +$2.61K
XFINW
5800
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
$20K ﹤0.01%
220,001

Similar funds

Goldman Sachs's Q3 2022 Portfolio in Review

As of Q3 2022, Goldman Sachs held 6,885 positions worth $396B, down 1.1% from $400B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Goldman Sachs deployed $17.3B of net new capital in Q3 2022, opening 459 new positions and adding to 2,707 existing holdings. Its largest new stake was Schwab US TIPS ETF: 8,348,958 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $930M trimmed.

  • Goldman Sachs's largest Q3 2022 buy was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
  • Goldman Sachs added most to Visa in Q3 2022, an estimated $2.06B increase.
  • Goldman Sachs's biggest Q3 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $930M.
  • Goldman Sachs fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $236M.
  • Goldman Sachs's ten largest holdings make up 18% of its $396B portfolio in Q3 2022.
  • Goldman Sachs opened 459 new positions and closed 646 in Q3 2022.
  • Goldman Sachs's portfolio value fell 1.1% quarter-over-quarter to $396B.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.